Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma
Pooja A. Shah(The University of Texas MD Anderson Cancer Center), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Hongyun Zhao(Sun Yat-sen University), Qi Wang(Tongji University), Tuhina Mazumdar(The University of Texas MD Anderson Cancer Center), Kazi Mokim Ahmed(University of California, Berkeley), Vaishnavi Sambandam(National Comprehensive Cancer Network), Mitchell J. Frederick(Baylor College of Medicine), Jing Wang(The University of Texas MD Anderson Cancer Center), Soma Ghosh(Weizmann Institute of Science), Li Shen(The University of Texas MD Anderson Cancer Center), Anne M. Fernandez(The University of Texas MD Anderson Cancer Center)
Cited by 11
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
|Developmental Cell|2014|389
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
|Cell Reports|2018|366
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
|Cancer Discovery|2023|181